Evidence map›Paper›PMID 26286633›Full record

ArticleScientific reports2015

A Nucleus-Imaging Probe That Selectively Stabilizes a Minor Conformation of c-MYC G-quadruplex and Down-regulates c-MYC Transcription in Human Cancer Cells.

Deepanjan Panda, Manish Debnath, Samir Mandal, Irene Bessi, Harald Schwalbe, Jyotirmayee Dash

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Selective Recognition ofACS medicinal chemistry letters · 2024
    Article
  3. Molecular Insights into the Specific Targeting ofInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Insights from Binding on Quadruplex Selective Carbazole Ligands.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Deepanjan PandaDepartment of Organic Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata-700032, India.
Manish DebnathDepartment of Organic Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata-700032, India.
Samir MandalDepartment of Organic Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata-700032, India.
Irene BessiInstitute of Organic Chemistry and Chemical Biology, Goethe University Frankfurt and Centre for Biomolecular, Magnetic Resonance, Max-von-Laue Strasse 7, 60438, Frankfurt am Main, Germany.
Harald SchwalbeInstitute of Organic Chemistry and Chemical Biology, Goethe University Frankfurt and Centre for Biomolecular, Magnetic Resonance, Max-von-Laue Strasse 7, 60438, Frankfurt am Main, Germany.
Jyotirmayee DashDepartment of Organic Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata-700032, India.
Indian Association for the Cultivation of Science · INGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The c-MYC proto-oncogene is a regulator of fundamental cellular processes such as cell cycle progression and apoptosis. The development of novel c-MYC inhibitors that can act by targeting the c-MYC DNA G-quadruplex at the level of transcription would provide potential insight into structure-based design of small molecules and lead to a promising arena for cancer therapy. Herein we report our finding that two simple bis-triazolylcarbazole derivatives can inhibit c-MYC transcription, possibly by stabilizing the c-MYC G-quadruplex. These compounds are prepared using a facile and modular approach based on Cu(I) catalysed azide and alkyne cycloaddition. A carbazole ligand with carboxamide side chains is found to be microenvironment-sensitive and highly selective for "turn-on" detection of c-MYC quadruplex over duplex DNA. This fluorescent probe is applicable to visualize the cellular nucleus in living cells. Interestingly, the ligand binds to c-MYC in an asymmetric fashion and selects the minor-populated conformer via conformational selection.

Indexed as

Down-RegulationTranscription, GeneticApoptosisCarbazolesCell CycleCell Line, TumorCell NucleusCell ProliferationCircular DichroismFlow CytometryFluorescence Resonance Energy TransferFluorescent DyesG-QuadruplexesHumansLigandsMolecular ProbesCarbazolesFluorescent DyesLigandsMAS1 protein, humanMolecular ProbesProto-Oncogene MasProto-Oncogene Proteins c-myc

Identifiers

PMID26286633
PMCPMC4541407
OpenAlexW1146966998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.